(Reuters) – Drug developer Minerva Neurosciences Inc said on Friday its experimental drug for schizophrenia did not meet the main goal of a late-stage study. The drug, roluperidone, did not show statistically significant...
Read More
(Reuters) – Healthcare professionals should closely monitor COVID-19 patients who are...
Read More
By Susana Vera MADRID (Reuters) – With air kisses and palms clasped, elderly patients in...
Read More
(Reuters) – A panel of the European health regulator on Friday recommended approving Johnson...
Read More
(Reuters) – AstraZeneca and Daiichi Sankyo’s Enhertu helped patients with three...
Read More
(Reuters) – Here’s what you need to know about the coronavirus right now: Hospitals...
Read More
(Reuters) – The European health regulator has vowed to conduct a speedy review of Gilead...
Read More
By Syed Raza Hassan KARACHI, Pakistan (Reuters) – A pharmaceutical company in Pakistan plans...
Read MoreBEIJING (Reuters) – China’s Ministry of Agriculture and Rural Affairs said on Friday it had found a new outbreak of African swine fever near the city of Lanzhou in northwestern Gansu province. More than 90 pigs had...
Read More